MedTrace Logo

Residual Sample Collection for Respiratory Viral Panel

NCT02049918 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1487

Last updated 2015-12-28

No results posted yet for this study

Summary

Collect de-identified, residual samples to support a clinical trial. Samples may be prospectively or retrospectively collected. Overall Study Objective Obtain clinical performance data to characterize clinical performance of the Respiratory Viral Panel on the GenMark Sample-to-Answer Platform.

Conditions

  • Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus

Sponsors & Collaborators

  • GenMark Diagnostics

    lead INDUSTRY

Principal Investigators

  • Wallace Green, PhD · Milton S. Hershey Medical Center

  • Michelle Fennell, MHA, MT(ASCP) · Ingalls Memorial Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02049918 on ClinicalTrials.gov